Tag Archives: Obama and Pharmaceutical firms again in cahoots on TPP

Obama and Pharmaceutical firms again in cahoots on TPP, Trans Pacific Partnership empowers big pharma, Greater access to and influence over decision making processes around pricing and reimbursement, Drug companies biggest spenders on lobbying

Obama and Pharmaceutical firms again in cahoots on TPP, Trans Pacific Partnership empowers big pharma, Greater access to and influence over decision making processes around pricing and reimbursement, Drug companies biggest spenders on lobbying

“If you like your health care plan, you’ll be able to keep your health care plan.”…Barack Obama

“millions of Americans are getting or are about to get cancellation letters for their health insurance under Obamacare, say experts, and the Obama administration has known that for at least three years.”…NBC News October 29, 2013

 

“We are being lied to on a scale unimaginable by George Orwell.”…Citizen Wells

 

From the NY Times June 10, 2015.

“Facing resistance from Pacific trading partners, the Obama administration is no longer demanding protection for pharmaceutical prices under the 12-nation Trans-Pacific Partnership, according to a newly leaked section of the proposed trade accord.”

“It was very clear to everyone except the U.S. that the initial proposal wasn’t about transparency. It was about getting market access for the pharmaceutical industry by giving them greater access to and influence over decision-making processes around pricing and reimbursement,” saidDeborah Gleeson, a lecturer at the School of Psychology and Public Health at La Trobe University in Australia. And even though the section, known as the transparency annex, has been toned down, she said, “I think it’s a shame that the annex is still being considered at all for the T.P.P.”

The annex, which covers pharmaceutical and medical devices, is the latest document obtained by The New York Times in collaboration with the watchdog group WikiLeaks, and it was released before the House vote on whether to give President Obama expanded powers to complete the Trans-Pacific Partnership.”

“The agreement “will increase the cost of medicines worldwide, starting with the 12 countries that are negotiating the Trans-Pacific Partnership,” said Judit Rius Sanjuan, a lawyer at Doctors Without Borders, a humanitarian organization that provides medical care in more than 60 countries.”

“Pharmaceutical firms and their trade associations have filed by far more lobbying disclosure forms on the Pacific trade negotiations than any other industry, according to the watchdog Sunlight Foundation. More broadly, the pharmaceutical and health product industries have been the biggest spenders on lobbying, and drug company deal-making with the Obama administration and in Congress was instrumental in securing passage of the Affordable Care Act.”

““The leak is just the latest glaring example of why fast-tracking the T.P.P. would undermine the health of Americans and the other countries and cost our government more, all to the benefit of pharma’s profits,” said Lori Wallach, director of Public Citizen’s Global Trade Watch and one of the most prominent voices in the coalition working to scuttle trade promotion authority.”

Read more:

http://www.nytimes.com/2015/06/11/business/international/us-shifts-stance-on-drug-pricing-in-pacific-trade-pact-talks-document-reveals.html?smid=tw-share&_r=0

Naw, Mr transparency, Obama, wouldn’t make a deal with the pharmaceutical companies would he?

From Citizen Wells August 23, 2009.

“Internal Memo Confirms Big Giveaways In White House Deal With Big Pharma
A memo obtained by the Huffington Post confirms that the White House and the pharmaceutical lobby secretly agreed to precisely the sort of wide-ranging deal that both parties have been denying over the past week.

The memo, which according to a knowledgeable health care lobbyist was prepared by a person directly involved in the negotiations, lists exactly what the White House gave up, and what it got in return.”

“Critics on Capitol Hill and online responded with outrage at the reports that Obama had gone behind their backs and sold the reform movement short. Furthermore, the deal seemed to be a betrayal of several promises made by then-Sen. Obama during the presidential campaign, among them that he would use the power of government to drive down the costs of drugs to Medicare and that negotiations would be conducted in the open.”

“the White House agreed to:

1. Oppose importation

2. Oppose rebates in Medicare Part D

3. Oppose repeal of non-interference

4. Oppose opening Medicare Part B”

“Here is a CNN report on this backroom deal:

“Obama:Caught Lying Again-Making Back Room Deals with Pharmaceutical Lobbyist”

https://citizenwells.com/2009/08/23/obama-pharmaceutical-memo-obama-lying-white-house-deal-with-pharmaceutical-lobby-phrma-internal-memo-pharmaceutical-researchers-and-manufacturers-association-deal-lobbyistsyoutube-video/